OpenVSafe by OpenVAERS
Search V-safe

CBB-23273-76297

3 vaccinations 8 coded responses 11 check-ins 7 free-text entries 8 call cases
Sex
Female
Age at first dose
12-15
ZIP prefix
234 / VA
Registered
2022-07-19
Relationship
Child or adolescent in my care
Guardian
ESN-18128-50422
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-06-29
    Dose 1 — Pfizer-BioNTech
  2. 2021-07-20
    Dose 2 — Pfizer-BioNTech
  3. 2022-07-15
    Dose 3 — Pfizer-BioNTech
  4. 2022-07-19
    Registered in v-safe
  5. 2022-07-19
    Survey response — days 1–6 daily, dose 3, dependent
    MedDRA: Emergency care, Hospitalisation, Intensive care, Myocarditis, Pericarditis — Feeling: Poor · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Pericarditis and myocarditis requiring emergency care, pediatric ICU admission, and associated cardiology evaluations and treatments
    MedDRA releases: 2024-11 · check-in free text available
  6. 2022-07-19
    Report sent to call center — days 1–6 daily, dose 3, dependent
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  7. 2022-07-20
    Survey response — days 1–6 daily, dose 3, dependent
    MedDRA: Chest pain, Implantable cardiac monitor insertion, Myocarditis, Pericarditis — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Systemic reaction (other): Myocarditis/Pericarditis chest pain · Healthcare visit (other): Repeat 12-lead ECG, troponin lab check, continuous cardiac monitoring device placement
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-07-20
    Report sent to call center — days 1–6 daily, dose 3, dependent
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  9. 2022-07-20
  10. 2022-07-21
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  11. 2022-07-21
  12. 2022-07-21
  13. 2022-07-21
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  14. 2022-07-22
    Survey response — day 7, dose 3, dependent
    MedDRA: Troponin increased, Unevaluable event — Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Systemic reaction (other): Troponin increased. If elevated tomorrow, need IVIG. · Healthcare visit (other): Labs, 12 lead EKG, echocardiogram
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-07-22
    Report sent to call center — day 7, dose 3, dependent
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  16. 2022-07-25
  17. 2022-07-27
  18. 2022-07-31
    Survey response — day 14, dose 3, dependent
    MedDRA: Hospitalisation, Intensive care, Myopericarditis, Office visit — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Readmitted to peds ICU last weekend for IVIG infusion due to worsening perimyocarditis. Discharged home, then readmitted to inpatient peds ward due to IVIG adverse reaction. Reevaluated in peds clinic after peds ward discharge.
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-07-31
    Report sent to call center — day 14, dose 3, dependent
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  20. 2022-08-05
    Health check-in — day 21, dose 3, dependent
    Feeling: Fair
    Adult check-in
  21. 2022-08-05
  22. 2022-08-05
  23. 2022-08-05
  24. 2022-08-05
  25. 2022-08-12
    Survey response — day 28, dose 3, dependent
    MedDRA: Tachycardia, Telemedicine — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Continued tachycardia episodes at rest and with activity. Cardiac MRI results received and are normal. · Healthcare visit (other): Telehealth with pediatric cardiologist
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-08-12
    Report sent to call center — day 28, dose 3, dependent
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  27. 2022-08-12
  28. 2022-08-12
  29. 2022-08-12
  30. 2022-08-12
  31. 2022-08-12
  32. 2022-08-21
    Survey response — day 35, dose 3, dependent
    MedDRA: Chest pain, Dizziness, Tachycardia, Troponin increased — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Troponin significantly more elevated. Reoccurrence or chest pain. Tachycardia episodes up to 140s. Dizziness.
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-08-21
    Report sent to call center — day 35, dose 3, dependent
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  34. 2022-08-22
  35. 2022-08-22
  36. 2022-08-22
  37. 2022-08-22
  38. 2022-08-22
  39. 2022-08-22
  40. 2022-08-22
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  41. 2022-08-22
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  42. 2022-08-22
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  43. 2022-08-22
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  44. 2022-08-28
    Survey response — day 42, dose 3, dependent
    MedDRA: Dizziness, Fatigue, Presyncope, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Persistent fatigue and continued tachycardia episodes, sometimes associated with dizziness and pre-syncope symptoms. Additional labs have been drawn to check for possible new high dose IVIG adverse effects.
    MedDRA releases: 2024-11 · check-in free text available
  45. 2022-08-28
    Report sent to call center — day 42, dose 3, dependent
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  46. 2022-08-30
  47. 2022-10-14
  48. 2023-01-13
    Survey response — 6 months, dose 3, dependent
    MedDRA: Cardiac disorder, Cognitive disorder, Physiotherapy, Vestibular disorder — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  49. 2023-01-13
    Report sent to call center — 6 months, dose 3, dependent
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  50. 2023-01-16
  51. 2023-01-16

Vaccinations

DoseDateManufacturerCo-administered
12021-06-29Pfizer-BioNTech No
22021-07-20Pfizer-BioNTech No
32022-07-15Pfizer-BioNTech No

Call center

8 call center cases

6 successful · 2 unsuccessful

VAERS report filed, before or during a call: 7

See the call center timeline

Free text

Release 12 — days 1–6 daily, dose 3, dependent

2022-07-19

Systemic reaction (other): Pericarditis and myocarditis requiring emergency care, pediatric ICU admission, and associated cardiology evaluations and treatments

2022-07-20

Systemic reaction (other): Myocarditis/Pericarditis chest pain
Healthcare visit (other): Repeat 12-lead ECG, troponin lab check, continuous cardiac monitoring device placement

Release 12 — day 7, dose 3, dependent

2022-07-22

Systemic reaction (other): Troponin increased. If elevated tomorrow, need IVIG.
Healthcare visit (other): Labs, 12 lead EKG, echocardiogram

Release 12 — day 14, dose 3, dependent

2022-07-31

Symptoms: Readmitted to peds ICU last weekend for IVIG infusion due to worsening perimyocarditis. Discharged home, then readmitted to inpatient peds ward due to IVIG adverse reaction. Reevaluated in peds clinic after peds ward discharge.

Release 12 — day 28, dose 3, dependent

2022-08-12

Symptoms: Continued tachycardia episodes at rest and with activity. Cardiac MRI results received and are normal.
Healthcare visit (other): Telehealth with pediatric cardiologist

Release 12 — day 35, dose 3, dependent

2022-08-21

Symptoms: Troponin significantly more elevated. Reoccurrence or chest pain. Tachycardia episodes up to 140s. Dizziness.

Release 12 — day 42, dose 3, dependent

2022-08-28

Symptoms: Persistent fatigue and continued tachycardia episodes, sometimes associated with dizziness and pre-syncope symptoms. Additional labs have been drawn to check for possible new high dose IVIG adverse effects.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOImplantable cardiac monitor insertion · · ✓
HCVOTelemedicine · · ✓
HCVOUnevaluable event · · ✓
SDCardiac disorder · · ✓
SDChest pain · · ✓
SDCognitive disorder · · ✓
SDDizziness · · ✓
SDFatigue · · ✓
SDHospitalisation · · ✓
SDIntensive care · · ✓
SDMyopericarditis · · ✓
SDOffice visit · · ✓
SDPhysiotherapy · · ✓
SDPresyncope · · ✓
SDTachycardia · · ✓
SDTroponin increased · · ✓
SDVestibular disorder · · ✓
SROChest pain · · ✓
SROEmergency care · · ✓
SROHospitalisation · · ✓
SROIntensive care · · ✓
SROMyocarditis · · ✓
SROPericarditis · · ✓
SROTroponin increased · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release